Latest News
13-Jul-2026 Pharma Body Renews Push for Data Protection
10-Jul-2026 Dr Reddy’s Pauses Weight Loss Drug on Quality Fears
09-Jul-2026 GLP-1 Drug Innovators Regain Weight as Generics Fall Behind
09-Jul-2026 Sun Pharma Urges SC to Halt Intas’ Drug Over Name Row
08-Jul-2026 Rajasthan Moves to 3-Tier Quality Checks for Drug Procurements
  more...
Latest Reports
Jul-26 Another healthy quarter ahead - Emkay Research  
Apr-26 Doors set to open for generic semaglutide in Canada - ICICI Securities  
Apr-26 Bed rock of growth: Structural strength meets strategic expansion - ICICI Securities  
Apr-26 IPM: 11% growth in Mar-26; 10% in FY26 - HDFC Securities  
Apr-26 US tariffs on branded drugs; generics exempted - HDFC Securities  
  more...

Quarterly Summary March-2026
Desc Current Previous Per.Chg
Sales 74642.3 76076.7 -1.9
Otherincome 3949.5 2779.7 42.1
Expense 57617.7 54983.3 4.8
RawMaterial 22040.3 20989.5 5.0
StaffCost 11711.1 10695.2 9.5
ExciseDuty 31.3 83.8 -62.7
OtherExp 17733.9 16934.6 4.7
Interest 1476.2 1361.8 8.4
GrossProfit 22124.9 23658.9 -6.5
Depreciation 3341.1 3112.3 7.4
Tax 3279.3 4641.5 -29.3
NetProfit 15019.1 16209.0 -7.3
Total.Comp 189 -- --
Source: ETIG Database

Sectoral Companies As on 13 Jul 2026
Company Name (Top 10) MarketCap (Rs.Crore)
Sun Pharma. 461637.32
Divi's Lab 184040.47
Torrent Phar 167461.80
Cipla 115264.04
Lupin 114209.62
Zydus Life 113806.25
Mankind Phar 103632.03
Dr.Reddy's 103052.06
Aurobindo Ph 90003.67
Laurus Labs 84149.34
Biocon 66907.33
Alkem Labora 66647.93
Glenmark Pha 64945.51
  click here for the complete list